Header Logo

Connection

BIYKEM BOZKURT to Aminobutyrates

Back to Details
This is a "connection" page, showing publications BIYKEM BOZKURT has written about Aminobutyrates.
BIYKEM BOZKURT
Connection Strength
1.479
Aminobutyrates
  1. Substance and Substrate: LVEF and Sex Subgroup Analyses of PARAGON-HF and PARADIGM-HF Trials. Circulation. 2020 02 04; 141(5):362-366.
    View in: PubMed
    Score: 0.634
  2. Ten years real-world experience with sacubitril/valsartan in patients with heart failure with reduced ejection fraction. ESC Heart Fail. 2026 Mar 03; 13(2).
    View in: PubMed
    Score: 0.242
  3. Mortality, Outcomes, Costs, and Use of?Medicines Following a First Heart?Failure?Hospitalization: EVOLUTION HF. JACC Heart Fail. 2023 10; 11(10):1320-1332.
    View in: PubMed
    Score: 0.200
  4. Heart?Failure Drug Treatment-Inertia,?Titration, and Discontinuation: A Multinational Observational Study (EVOLUTION HF). JACC Heart Fail. 2023 01; 11(1):1-14.
    View in: PubMed
    Score: 0.190
  5. Ins and Outs: Perspectives of Inpatient Prescribing for Sacubitril/Valsartan. Ann Pharmacother. 2021 06; 55(6):805-813.
    View in: PubMed
    Score: 0.167
  6. The year in cardiovascular medicine 2021: heart failure and cardiomyopathies. Eur Heart J. 2022 Feb 03; 43(5):367-376.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.